Literature DB >> 2032396

The successful treatment of atypical hemolytic uremic syndrome with plasmapheresis.

W L Robson1, A K Leung.   

Abstract

A seven and a half-year-old boy presented with idiopathic atypical hemolytic uremic syndrome (HUS). He initially appeared to respond to plasma infusions. When he became refractory to plasma infusion, plasmapheresis was initiated. The treatment with plasmapheresis dramatically reversed the deterioration in glomerular filtration rate and platelet count. The use of plasma infusion and plasmapheresis in HUS is discussed. The authors advise the use of plasmapheresis in idiopathic atypical HUS.

Entities:  

Mesh:

Year:  1991        PMID: 2032396

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  Risk factors for poor renal prognosis in children with hemolytic uremic syndrome.

Authors:  Alessandra Gianviti; Alberto E Tozzi; Laura De Petris; Alfredo Caprioli; Lucilla Ravà; Alberto Edefonti; Gianluigi Ardissino; Giovanni Montini; Graziella Zacchello; Alfonso Ferretti; Carmine Pecoraro; Tommaso De Palo; Angela Caringella; Maurizio Gaido; Rosanna Coppo; Francesco Perfumo; Nunzia Miglietti; Ilse Ratsche; Rosa Penza; Giovambattista Capasso; Silvio Maringhini; Salvatore Li Volti; Carmen Setzu; Marco Pennesi; Alberto Bettinelli; Leopoldo Peratoner; Ivana Pela; Elio Salvaggio; Giuliana Lama; Salvatore Maffei; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

2.  Atypical relapse of hemolytic uremic syndrome after transplantation.

Authors:  Karolien H Olie; Sandrine Florquin; Jaap W Groothoff; René Verlaak; Lisa Strain; Timothy H J Goodship; Jan J Weening; Jean-Claude Davin
Journal:  Pediatr Nephrol       Date:  2004-08-05       Impact factor: 3.714

3.  Haemolytic uraemic syndrome: prognostic factors in children over 3 years of age.

Authors:  C Renaud; P Niaudet; M F Gagnadoux; M Broyer; R Habib
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.